Pitt St Research initiates coverage on AFT Pharmaceuticals

Pitt St Research initiates coverage on AFT Pharmaceuticals AFT Pharmaceuticals (NZX: AFT; ASX: AFP), today announces that Pitt St Research has initiated coverage on AFT Pharmaceuticals Ltd. Pitt St is an Australian based research organisation providing issuer-sponsored equity research on ASX-listed life sciences companies since 2016. The report is available on the AFT Pharmaceuticals website. The views contained in the report are the views of Pitt St Research. Released for, and on behalf of, AFT Pharmaceuticals Limited by Stuart Houliston, Chief Financial Officer. For more information: Investors Media Dr Hartley Atkinson Richard Inder Managing Director The Project AFT Pharmaceuticals Tel: +64 21 645 643 Tel: +64 9488 0232